Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

bassat2018_2990.pdf (111.75 KB)

Document type

Article

Version

Published version

Publication date

2018-04-07

Publication license

cc by-nc-nd (c) Bassat Orellana, Quique; Krishna, Sanjeev, 2018
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/121846

Widening the options for recurrent malaria

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1016/S0140-6736(18)30630-5

Abstract

The global need for new antimalarial drugs and new combinations is enormous and urgent,1, 2 but their successful delivery needs resilience to overcome the barriers imposed by expensive and lengthy clinical development plans. Attention is often directed to areas such as southeast Asia, where some antimalarial combinations are failing but transmission intensities are much lower than in sub-Saharan African countries. Children in Africa have frequent and life-threatening malaria infections as they grow up, and these need to be treated safely.

Subject

Malària, Vacuna de la malària

Subject (English)

Malaria, Malaria vaccine

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

BASSAT ORELLANA, Quique and KRISHNA, Sanjeev. Widening the options for recurrent malaria. Lancet. 2018. Vol. 391, num. 10128, pags. 1336-1338. ISSN 0140-6736. [consulted: 20 of August of 2026]. Available at: https://hdl.handle.net/2445/121846

Export metadata

JSON - METS

Share record